Registration
UPSTREAM CONSULTING for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Firm
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the implementation of the Patient Protection and Affordable Care Act; Medicare coverage for certain cancer therapies; Comparative Effectiveness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN M. HADDOW New | Legislative Assistant, Senator Orrin Hatch |
| MATTHEW SALMON New | U.S. Representative from Arizona's 1st District |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Japan | Japan | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.